Kelly Qiao - Profile and Investment Details

Investor Profile

Kelly Qiao is a Venture Capital, Private Equity Firm, Investor based in China with a diverse investment portfolio that includes companies such as Phoenix Healthcare Group Co Ltd, Grit Biotechnology, Fosun Group, Shenzhen Chipscreen Biosciences Co., Ltd., Taikang Insurance Group Inc., ProfoundBio, 镁信健康, Beijing Yuanxin Technology Co., Ltd., Vivacta Biotechnology, vertex ventures, Spectrumedics International, Insilico Medicine, MacroLux Medical Technology Co., Ltd., AlphaLife Sciences, Rona Therapeutics, . Over time, Kelly Qiao has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Kelly Qiao is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Clean Tech, Health Care, South East Asia-based Startups, Talent Management, Wellness, Enterprise Software, Fundraising, Investment Management, Customer Engagement, Energy, Healthcare Innovation, Strategic Partnerships, Portfolio Management, Startups, Business Development, Technology, Finance, Intellectual Property, Electronic Health Records (EHR), Health and Hospital Services, Innovation, Clinical Trials, FinTech, Consumer Software, Consulting, Utilities, Digital Health, Renewable Energy, Medical, Information Technology, B2B, Health Tech, Media and Entertainment, Healthcare Technology, Risk Management may find it worthwhile to explore potential connections with Kelly Qiao, as their portfolio suggests a familiarity and interest in this area.

Understanding Kelly Qiao’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.